Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.4.1859

All-trans-retinoic Acid Promotes Iodine Uptake Via Up-regulating the Sodium Iodide Symporter in Medullary Thyroid Cancer Stem Cells  

Tang, Min (Department of Radiation Medicine, The First Affiliated Hospital, Chongqing Medical University)
Hou, Yan-Li (Department of Radiation Medicine, The First Affiliated Hospital, Chongqing Medical University)
Kang, Qiang-Qiang (Department of Radiation Medicine, The First Affiliated Hospital, Chongqing Medical University)
Chen, Xing-Yue (Department of Radiation Medicine, The First Affiliated Hospital, Chongqing Medical University)
Duan, Li-Qun (Department of Radiation Medicine, The First Affiliated Hospital, Chongqing Medical University)
Shu, Jin (Department of Radiation Medicine, The First Affiliated Hospital, Chongqing Medical University)
Li, Shao-Lin (Department of Radiation Medicine, The First Affiliated Hospital, Chongqing Medical University)
Hu, Xiao-Li (Department of Nuclear Medical, The First Affiliated Hospital, Chongqing Medical University)
Peng, Zhi-Ping (Department of Radiation Medicine, The First Affiliated Hospital, Chongqing Medical University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.4, 2014 , pp. 1859-1862 More about this Journal
Abstract
Recently, the main therapy of medullary thyroid cancer (MTC) is surgical, but by which way there is a poor prognosis with a mean survival of only 5 years. In some cases, some researchers found that it is the medullary thyroid cancer stem cells (MTCSCs) that cause metastasis and recurrence. This study aimed to eradicate MTCSCs through administration of all-trans-retinoic acid (ATRA). Here we demonstrate that MTCSCs possess stemlike properties in serum-free medium. The ABCG2, OCT4 and sodium iodide symporter (NIS) were changed by ATRA. Additionally, we found that ATRA can increase the expression of NIS in vivo. All the data suggested that ATRA could increase the iodine uptake of MTCSCs through NIS.
Keywords
ATRA; medullary thyroid carcinoma stem cells; the capability of radioiodine uptake; $^{131}I$;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Martin LP, Hamilton TC, Schilder RJ (2008). Platinum resistance: the role of DNA repair pathways. Clin Cancer Res, 14, 1291-5.   DOI   ScienceOn
2 Doha'n O, Carrasco N (2003). Advances in Na (+)/I (-) symporter (NIS) research in the thyroid and beyond. Mol Cell Endocrinol, 213, 59-70.   DOI   ScienceOn
3 Collins SJ (2002). The role of retinoids and retinoic acid receptors in normal hematopoiesis. Leukemia, 16, 1896-905.   DOI   ScienceOn
4 Damle N, Patnecha M, Kumar P, et al (2011). Retinoic acid therapy in patients with radioiodine negative differentiated thyroid cancer and clinical or biochemical evidence of disease: An initial experience. Indian J Nucl Med, 26, 144-8.   DOI   ScienceOn
5 Doha'n O, De la Vieja A, Paroder V, et al (2003). The sodium/ iodide symporter (NIS): characterization, regulation, and medical significance. Endocr Rev, 24, 48-77.   DOI   ScienceOn
6 Elola M, Yoldi A, Emparanza JI, et al (2011). Redifferentiation therapy with rosiglitazone in a case of differentiated thyroid cancer with pulmonary metastases and absence of radioiodine uptake. Rev Esp Med Nucl, 30, 241-3.   DOI   ScienceOn
7 Foujilas C, Marakaki C, Sirmos N (2009). Sodium-iodine symporter in thyroid, normal and cancer tissues and its relation to nuclear medicine and to gene cloning treatment. Hell J Nucl Med, 12, 189-93.
8 Francipane MG, Chandler J, Lagasse E (2013). Cancer stem cells: a moving target. Curr Pathobiol Rep, 1, 111-8.   DOI   ScienceOn
9 Hadnagy A, Gaboury L, Beaulieu R, Balicki D (2006). SP analysis may be used to identify cancer stem cell populations. Exp Cell Res, 312, 3701-10.   DOI   ScienceOn
10 Jiang W, Peng J, Zhang Y, et al (2012). The implications of cancer stem cells for cancer therapy. Int J Mol Sci, 13, 16636-57.   DOI   ScienceOn
11 Tseng LM, Huang PI, Chen YR, et al (2012). Targeting signal transducer and activator of transcription 3 pathway by cucurbitacin I diminishes self-renewing and radiochemoresistant abilities in thyroid cancer-derived CD133+ cells. J Pharmacol Exp Ther, 341, 410-23.   DOI
12 Weiss SJ, Philp NJ, Grollman EF (1984). Iodide transport in a continuous line of cultured cells from rat thyroid. Endocrinology, 114, 1090-8.   DOI   ScienceOn
13 Yu J, Vodyanik MA, Smuga-Otto K, et al (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science, 318, 1917-20.   DOI   ScienceOn
14 Jordan CT, Guzman ML, Noble M (2006). Cancer stem cells. N Engl J Med, 355, 1253-61.   DOI   ScienceOn
15 Lin RY (2011). Thyroid cancer stem cells. Nat Rev Endocrinol, 7, 609-16.   DOI   ScienceOn
16 Lobo NA, Shimono Y, Qian D, et al (2007). The biology of cancer stem cells. Annu Rev Dev Bio, 23, 675-99.   DOI   ScienceOn
17 Rashidi A, Goudar RK, Sayedian F, et al (2013). All-trans retinoic acid and early mortality in acute promyelocytic leukemia. Leuk Res, 37, 1391-2.   DOI   ScienceOn
18 Reya T, Morrison SJ, Clarke MF, et al (2001). Weissman IL. Stem cells and cancer stem cells. Nature, 414, 105-11.   DOI   ScienceOn
19 Ryan J, Curran CE, Hennessy E, et al (2011). The sodium iodide symporter (NIS) and potential regulators in normal, benign and malignant human breast tissue. PLoS One, 6, e16023.   DOI   ScienceOn
20 Schmutzler C, Winzer R, Meissner-Weigl J, et al (1997). Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells. Biochem Biophys Res Commun, 240, 832-8.   DOI   ScienceOn
21 Segalla S, Rinaldi L, Kilstrup-Nielsen C, et al (2003). Retinoic acid receptor alpha fusion to PML affects its transcriptional and chromatin-remodeling properties. Mol Cell Biol, 23, 8795-808.   DOI   ScienceOn
22 Tabarestani S, Ghafouri-Fard S (2012). Cancer stem cells and response to therapy. Asian Pac J Cancer Prev, 13, 5947-54.   DOI   ScienceOn
23 Takahashi K, Yamanaka S (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126, 663-76.   DOI   ScienceOn
24 Baumann M, Krause M, Hill R (2008). Exploring the role of cancer stem cells in radioresistance. Nat Rev Cancer, 8, 545-54.   DOI   ScienceOn
25 Biermann K, Biersack HJ, Sabet A, et al (2011). Alternative therapeutic approaches in the treatment of primary and secondary dedifferentiated and medullarythyroid carcinoma. Semin Nucl Med, 41, 139-48.   DOI   ScienceOn
26 Ailles LE, Weissman IL (2007). Cancer stem cell in solid tumor. Curr Opin Biotechnol, 18, 460-6.   DOI   ScienceOn
27 Bao S, Wu Q, McLendon RE, et al (2006). Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature, 444, 756-60.   DOI   ScienceOn
28 Christina Zechel (2005). Requirement of retinoic acid receptor isotypes alpha, beta and gamma during the initial steps of neural differentiation of PCC7 cells. Mol Endocrinol, 19, 1629-45.   DOI   ScienceOn
29 Tomita A, Kiyoi H, Naoe T (2013). Mechanisms of action and resistance to all-trans retinoic acid (ATRA) and arsenic trioxide (As2O 3) in acute promyelocytic leukemia. In J Hematol, 97, 717-25.
30 Zhang AM, Fan Y, Yao Q, et al (2012).Identification of a cancer stem-like population in the Lewis lung cancer cell line. Asian Pacific J Cancer Prev, 13, 761-6.   DOI   ScienceOn
31 Cunha De Santis G, Tamarozzi MB, Sousa RB, et al (2007). Adhesion molecules and differentiation syndrome: phenotypic and functional analysis of the effect of ATRA, $As_{2}O_{3}$, phenylbutyrate, and G-CSF in acute promyelocytic leukemia. Haematologica, 92, 1615-22.   DOI   ScienceOn